Submitted by Anonymous (not verified) on 22 September 2023 - 16:20
Human medicines European public assessment report (EPAR): Lenalidomide Accord, lenalidomide, Multiple Myeloma, Date of authorisation: 20/09/2018, Revision: 11, Status: Authorised
Source: